Company intelligence
Medicines Patent Pool
Increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries.
About Medicines Patent Pool
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies. MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada and the World Intellectual Property Organization (WIPO). MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.
Verified activity
Signals from Medicines Patent Pool
7 published signals
People
Medicines Patent Pool welcomed Serge SAGODIRA as its new Business Development and Partnerships Director.
Reported by Medicines Patent Pool
People
Medicines Patent Pool extended the application deadline for Senior Associate, BD – Alliance Management at MPP, Mumbai to 21 September 2026.
Reported by Medicines Patent Pool
Products & Services
Medicines Patent Pool released the latest version of Medspal, including advanced reporting tools with interactive maps, donut charts, and timelines, and dedicated licence tabs in both Table and Reports views.
Reported by Medicines Patent Pool
Partnerships
Medicines Patent Pool partnered with the University of Liverpool's Centre of Excellence for Long-acting Therapeutics - Global Health to curate the LAPaL database and receive funding from Unitaid Coefficient Giving and The National Institutes of Health through the Long-Acting Extended Release Antiretroviral Research Resource Program (LEAP).
Reported by Medicines Patent Pool
Presence & Recognition
Medicines Patent Pool hosted the Health Innovation for Public Benefit event at the European Parliament in Brussels on Wednesday, September 9, 2026, featuring speakers including Nicolás González Casares, Esteban Burrone, Judit R., Dessie Tarlton, Michael Makanga, Dessie Tarlton, Michael Makanga, and others.
Reported by Medicines Patent Pool
Research & Knowledge
Medicines Patent Pool published a new paper titled Paediatric Drug Optimization for Sickle Cell Disease: priorities for research and development in children in The Lancet Child & Adolescent Health, with MPP contributing as a co-author.
Reported by Medicines Patent Pool
Presence & Recognition
Medicines Patent Pool employee Giulia Segafredo will join the Global Accelerator for Paediatric Formulations for Paediatric Formulations on 2 September.
Reported by Medicines Patent Pool